Navigation Links
Genomma Lab Announces Updated Fourth Quarter 2008 Guidance

MEXICO CITY, Jan. 13 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces that based on the main preliminary indicators obtained at the close of the fourth quarter of 2008, the Company expects to report slightly lower results than the original growth expectations. However, product sales at the point of sale continue to be in line with original projections.

Despite favorable acceptance at the point of sale, some of Genomma Lab's clients chose to marginally reduce inventory levels during the last two weeks of December, in light of the current economic situation.

During the fourth quarter, the Company maintained a strict focus on working capital, placing the Company in a very solid position in terms of liquidity.

Genomma Lab will report fourth quarter results on February 17, 2009, followed by the quarterly conference call, which will take place on the following day.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab's shares trade on the Mexican Stock Exchange under the ticker symbol "LAB".

    Web Site:

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250

    In New York:
    i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Genomma Lab, New Participant in Market-Maker Program
2. Genomma Lab Announces Initiation of Stock Repurchase Fund
3. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
4. Genomma Lab Announces 2009 Earnings Guidance
5. Genomma Lab Internacional Acquires UNIGASTROZOL
6. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
7. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
8. American Journal of Nursing announces 2008 Book of the Year Awards
9. AllMed Announces PeerScore Solutions for Hospital Peer Review
10. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
11. Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: